The global interventional cardiology devices market size is calculated at USD 15.95 billion in 2025 and is forecasted to reach around USD 29.9 billion by 2034, accelerating at a CAGR of 7.24% from 2025 to 2034. The North America interventional cardiology devices market size surpassed USD 6.70 billion in 2024 and is expanding at a CAGR of 7.34% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Interventional Cardiology Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Interventional Cardiology Devices Market, by Product Type, 2025-2034
8.1.1. Angioplasty Balloons
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Angioplasty Stents
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Angioplasty Catheters
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Endovascular Aneurysm Repair Stent Grafts
8.1.4.1. Market Revenue and Forecast (2022-2034)
8.1.5. Inferior Vena Cava (IVC) Filters
8.1.5.1. Market Revenue and Forecast (2022-2034)
8.1.6. Plaque Modification Devices
8.1.6.1. Market Revenue and Forecast (2022-2034)
8.1.7. Hemodynamic Flow Alteration Devices
8.1.7.1. Market Revenue and Forecast (2022-2034)
8.1.8. Accessories
8.1.8.1. Market Revenue and Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Product (2022-2034)
10.1. Boston Scientific Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Edward Lifesciences Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Abbott
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. BIOTRONIK SE & Co. KG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. iVascular
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Terumo Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. B. BarunMelsungen
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Biosensors International Group
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Cardinal Health
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample